Oral and Maxillofacial tissue penetration of Sitafloxacin following oral administration of single 100 mg dose

Oral and Maxillofacial tissue penetration of Sitafloxacin following oral administration of single 100 mg dose - Oral and Maxillofacial penetration of Sitafloxacin

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014556

Enrollment

Registered

2014-07-15

Start date

2014-07-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impacted third molar teeth

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who needs to extract the third molar teeth

Exclusion criteria

Exclusion criteria: 1.Patients with allergies to any other antibiotics. 2.Patients who are pregnant or trying to get pregnant, or during the breastfeeding. 3.Patients who has disease that needs medical attention in the emergency, or who has liver,kidney and heart failure. 4.Patients with epilepsy.

Design outcomes

Primary

Measure	Time frame
Exam the transfer of Sitafloxacin into serum, gingiva, dental follicles, and madibular bone after 2.0 to 4.5h following oral administration of a single 100mg dose of Sitafloxacin.	—

Countries

Japan

Contacts

Public ContactSeiji Asoda

School of Medicine, Keio University Department of Dentistry and Oral Surgery

asoda@z3.keio.jp03-3353-1205

Outcome results